Literature DB >> 12076715

Relationship between the histological degrees of hepatitis and the postoperative recurrence of hepatocellular carcinoma in patients with hepatitis C.

Koji Matsumoto1, Jiro Yoshimoto, Hiroyuki Sugo, Kuniaki Kojima, Shunji Futagawa, Toshiharu Matsumoto.   

Abstract

The relationship between the recurrence of hepatocellular carcinoma (HCC) and the degree of inflammation was evaluated in resected livers with the hepatitis C virus (HCV) -associated HCC. Seventy-three patients with HCV-associated HCC who were followed up for more than 2 years were selected for this study. In these cases, the degree of chronic hepatitis in noncancerous regions at the time of surgery was classified according to the New Inuyama Classification as follows, the degree of necroinflammatory activity (Grading) was graded from A0 to A3, and the degree of fibrosis (Staging) was staged on F0-F4. In addition, among these patients, 41 patients who were followed by blood tests every 3 months were divided into two groups (high or low group) according to annual average levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), the platelet counts (Plt), and alpha-fetoprotein (AFP). As a result, cancer-free survival rate was significantly lower in the high-grade group (A3) than in the low-grade group (A1 or 2) (P=0.01). The high ALT (>80 IU) group and the high AFP (>20 mg/ml) group also had significantly worse cancer-free survival rate than the low ALT group and the low AFP group (P=0.04 for ALT, P=0.03 for AFP). A multivariate analysis for the prognostic values revealed the AFP level (P=0.02) and the Grading (P=0.04) were useful as independent prognostic factors concerning recurrence. In conclusion, the degree of inflammatory activity (Grading) is considered to be a useful factor regarding recurrence after liver resection in patients with HCC. Furthermore, the inhibition of inflammation in remnant liver may also contribute to the prevention of recurrence.

Entities:  

Year:  2002        PMID: 12076715     DOI: 10.1016/s1386-6346(01)00180-2

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  14 in total

1.  Prognosis of Hepatocellular Carcinoma Patients Who Achieved Long-Term Recurrence-Free Survival After Curative Therapy: Impact of the ALBI Grade.

Authors:  Hajime Matsushima; Yuko Takami; Tomoki Ryu; Munehiro Yoshitomi; Masaki Tateishi; Yoshiyuki Wada; Hideki Saitsu
Journal:  J Gastrointest Surg       Date:  2018-05-07       Impact factor: 3.452

2.  Laparoscopic liver resection in obese patients.

Authors:  Kan Toriguchi; Etsuro Hatano; Takaki Sakurai; Satoru Seo; Kojiro Taura; Shinji Uemoto
Journal:  World J Surg       Date:  2015-05       Impact factor: 3.352

3.  Interleukin-17A Plays a Pivotal Role in Chemically Induced Hepatocellular Carcinoma in Mice.

Authors:  Chao Sun; Hiroshi Kono; Shinji Furuya; Michio Hara; Kazuyoshi Hirayama; Yoshihiro Akazawa; Yuuki Nakata; Hideki Fujii
Journal:  Dig Dis Sci       Date:  2016-02       Impact factor: 3.199

4.  An operative case of hepatic pseudolymphoma difficult to differentiate from primary hepatic marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.

Authors:  Michihiro Hayashi; Noboru Yonetani; Fumitoshi Hirokawa; Mitsuhiro Asakuma; Katsuhiko Miyaji; Atsushi Takeshita; Kazuhiro Yamamoto; Hironori Haga; Takayuki Takubo; Nobuhiko Tanigawa
Journal:  World J Surg Oncol       Date:  2011-01-13       Impact factor: 2.754

Review 5.  HCC: current surgical treatment concepts.

Authors:  F Cauchy; D Fuks; J Belghiti
Journal:  Langenbecks Arch Surg       Date:  2012-06       Impact factor: 3.445

6.  Survival and recurrences after hepatic resection or radiofrequency for hepatocellular carcinoma in cirrhotic patients: a multivariate analysis.

Authors:  Marco Montorsi; Roberto Santambrogio; Paolo Bianchi; Matteo Donadon; Eliana Moroni; Antonino Spinelli; Mara Costa
Journal:  J Gastrointest Surg       Date:  2005-01       Impact factor: 3.452

7.  Protective effect of Juzen-taiho-to on hepatocarcinogenesis is mediated through the inhibition of Kupffer cell-induced oxidative stress.

Authors:  Masato Tsuchiya; Hiroshi Kono; Masanori Matsuda; Hideki Fujii; Ivan Rusyn
Journal:  Int J Cancer       Date:  2008-12-01       Impact factor: 7.396

8.  Surgical treatment of hepatocellular carcinoma.

Authors:  Jacques Belghiti; Reza Kianmanesh
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

9.  Fibrosis and inflammatory activity in noncancerous tissue and mitotic index of cancer tissue in patients with hepatocellular carcinoma: relationship to clinicopathological factors and prognosis after hepatic resection.

Authors:  Atsushi Nanashima; Kenji Tanaka; Hiroyuki Yamaguchi; Shinichi Shibasaki; Shigeyuki Morino; Megumi Yoshinaga; Terumitsu Sawai; Tohru Nakagoe; Hiroyoshi Ayabe
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

10.  Prospective evaluation of microscopic extension using whole-mount preparation in patients with hepatocellular carcinoma: Definition of clinical target volume for radiotherapy.

Authors:  Weihu Wang; Xiaoli Feng; Tao Zhang; Jing Jin; Shulian Wang; Yueping Liu; Yongwen Song; Xinfan Liu; Zihao Yu; Yexiong Li
Journal:  Radiat Oncol       Date:  2010-08-23       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.